Phoenix Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Phoenix Financial's AZN Position: Q3 2026 in Review
Phoenix Financial increased its AstraZeneca (AZN) stake by 21% in Q3 2026, buying an estimated $681K and bringing the position to 23,453 shares worth $2.89M. The position accounts for 0.02% of the portfolio, ranked #167.
Phoenix Financial first reported a position in AZN in Q4 2020 and has held it in 23 quarters since. The position peaked at $118M in Q4 2021. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Phoenix Financial held 23,453 shares of AstraZeneca worth $2.89M as of Q3 2026.
- Phoenix Financial bought 4,088 AstraZeneca shares in Q3 2026, an estimated $681K.
- AstraZeneca made up 0.02% of Phoenix Financial's portfolio in Q3 2026, its #167 holding.
- Phoenix Financial first reported a position in AstraZeneca in Q4 2020 and has held it in 23 quarters since.
- Phoenix Financial's AstraZeneca position peaked at $118M in Q4 2021.
- 918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Phoenix Financial's 13F filing for Q3 2026, filed 9 Nov 2026.